Skip to main content
Erschienen in: Inflammation 4/2012

01.08.2012

Suppressive Effects of N-Acetyl-d-Glucosamine on Rheumatoid Arthritis Mouse Models

verfasst von: Kazuo Azuma, Tomohiro Osaki, Takashi Wakuda, Takeshi Tsuka, Tomohiro Imagawa, Yoshiharu Okamoto, Saburo Minami

Erschienen in: Inflammation | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

We examined effects of N-acetyl-d-glucosamine (GlcNAc) on rheumatoid arthritis (RA) mouse models and effects of GlcNAc and glucosamine hydrochloride (GlcN) on several serum cytokine productions in RA mouse models. SKG/jcl mice were divided into control, GlcNAc, and GlcN groups. For 56 days, the control group received normal food, the GlcNAc group received 0.5 % GlcNAc-containing food, and the GlcN group received 0.5 % GlcN-containing food. GlcNAc and GlcN equally suppressed arthritis scores and histopathological scores compared to the control group. In the GlcN group, serum tumor necrosis factor-α and interleukin (IL)-6 concentrations were significantly decreased compared to the control group. In the GlcNAc group, serum IL-10, transforming growth factor β-1, and IL-2 concentrations were significantly increased compared to the control group. Our results indicated that GlcNAc also has suppressive effects on experimental RA in mouse models. The results of serum cytokine concentrations suggested that compared to GlcN, GlcNAc has a different suppressive mechanism in experimental RA models.
Literatur
1.
Zurück zum Zitat Anderson, J.W., R.J. Nicolosi, and J.F. Borzelleca. 2005. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food and Chemical Toxicology 43(2): 187–201.PubMedCrossRef Anderson, J.W., R.J. Nicolosi, and J.F. Borzelleca. 2005. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food and Chemical Toxicology 43(2): 187–201.PubMedCrossRef
2.
Zurück zum Zitat Chen, J.K., C.R. Shen, and C.L. Liu. 2010. N-Acetylglucosamine: production and applications. Marine Drugs 8(9): 2493–2516.PubMedCrossRef Chen, J.K., C.R. Shen, and C.L. Liu. 2010. N-Acetylglucosamine: production and applications. Marine Drugs 8(9): 2493–2516.PubMedCrossRef
3.
Zurück zum Zitat Shikhman, A.R., D.C. Brinson, J. Valbracht, and M.K. Lotz. 2009. Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes. Osteoarthritis and Cartilage 17(8): 1022–1028.PubMedCrossRef Shikhman, A.R., D.C. Brinson, J. Valbracht, and M.K. Lotz. 2009. Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes. Osteoarthritis and Cartilage 17(8): 1022–1028.PubMedCrossRef
4.
Zurück zum Zitat Hua, J., K. Sakamoto, T. Kikukawa, C. Abe, H. Kurosawa, and I. Nagaoka. 2007. Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes. Inflammation Research 56(10): 432–438.PubMedCrossRef Hua, J., K. Sakamoto, T. Kikukawa, C. Abe, H. Kurosawa, and I. Nagaoka. 2007. Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes. Inflammation Research 56(10): 432–438.PubMedCrossRef
5.
Zurück zum Zitat Ngian, G.S. 2010. Rheumatoid arthritis. Australian Family Physician 39(9): 626–628.PubMed Ngian, G.S. 2010. Rheumatoid arthritis. Australian Family Physician 39(9): 626–628.PubMed
6.
Zurück zum Zitat Hua, J., S. Suguro, S. Hirano, K. Sakamoto, and I. Nagaoka. 2005. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflammation Research 54(3): 127–132.PubMedCrossRef Hua, J., S. Suguro, S. Hirano, K. Sakamoto, and I. Nagaoka. 2005. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflammation Research 54(3): 127–132.PubMedCrossRef
7.
Zurück zum Zitat Sakaguchi, N., T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426(6965): 454–460.PubMedCrossRef Sakaguchi, N., T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426(6965): 454–460.PubMedCrossRef
8.
Zurück zum Zitat Hata, H., N. Sakaguchi, H. Yoshitomi, Y. Iwakura, K. Sekikawa, Y. Azuma, C. Kanai, E. Moriizumi, T. Nomura, T. Nakamura, and S. Sakaguchi. 2004. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. Journal of Clinical Investigation 114(4): 582–588.PubMed Hata, H., N. Sakaguchi, H. Yoshitomi, Y. Iwakura, K. Sekikawa, Y. Azuma, C. Kanai, E. Moriizumi, T. Nomura, T. Nakamura, and S. Sakaguchi. 2004. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. Journal of Clinical Investigation 114(4): 582–588.PubMed
9.
Zurück zum Zitat Yoshitomi, H., N. Sakaguchi, K. Kobayashi, G.D. Brown, T. Tagami, T. Sakihama, et al. 2005. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. The Journal of Experimental Medicine 201(6): 949–960.PubMedCrossRef Yoshitomi, H., N. Sakaguchi, K. Kobayashi, G.D. Brown, T. Tagami, T. Sakihama, et al. 2005. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. The Journal of Experimental Medicine 201(6): 949–960.PubMedCrossRef
10.
Zurück zum Zitat Lee, E.K., S.M. Kang, D.J. Paik, J.M. Kim, and J. Youn. 2005. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. International Immunology 17(3): 325–333.PubMedCrossRef Lee, E.K., S.M. Kang, D.J. Paik, J.M. Kim, and J. Youn. 2005. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. International Immunology 17(3): 325–333.PubMedCrossRef
11.
Zurück zum Zitat Hawkey, C., A. Kahan, K. Steinbrück, C. Alegre, E. Baumelou, B. Bégaud, et al. 1998. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. British Journal of Rheumatology 37(10): 937–945.PubMedCrossRef Hawkey, C., A. Kahan, K. Steinbrück, C. Alegre, E. Baumelou, B. Bégaud, et al. 1998. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. British Journal of Rheumatology 37(10): 937–945.PubMedCrossRef
12.
Zurück zum Zitat Bianchi, A., Bécuwe, P., Dauça, M., Netter, P., Magdalou, J., Terlain, B., and Bordji, K. 2002. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Letters 510(3): 166–170. Bianchi, A., Bécuwe, P., Dauça, M., Netter, P., Magdalou, J., Terlain, B., and Bordji, K. 2002. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway. FEBS Letters 510(3): 166–170.
13.
Zurück zum Zitat Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunology Reviews 212: 8–27.CrossRef Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunology Reviews 212: 8–27.CrossRef
14.
Zurück zum Zitat Nistala, K., and L.R. Wedderburn. 2009. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford, England) 48(6): 602–606.CrossRef Nistala, K., and L.R. Wedderburn. 2009. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford, England) 48(6): 602–606.CrossRef
Metadaten
Titel
Suppressive Effects of N-Acetyl-d-Glucosamine on Rheumatoid Arthritis Mouse Models
verfasst von
Kazuo Azuma
Tomohiro Osaki
Takashi Wakuda
Takeshi Tsuka
Tomohiro Imagawa
Yoshiharu Okamoto
Saburo Minami
Publikationsdatum
01.08.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9459-0

Weitere Artikel der Ausgabe 4/2012

Inflammation 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.